Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model

Diabetes

Volumn 55, Issue 1, 2006, Pages 93-101

  Werstuck, Geoff H ^a,b   Khan, Mohammad I ^a   Femia, Giuseppe ^a   Kim, Anna J ^a   Tedesco, Vivienne ^a   Trigatti, Bernardo ^a   Shi, Yuanyuan ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b HENDERSON RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; GLUCOSAMINE; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; CELL TYPE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FATTY LIVER; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VIVO STUDY; LIPID METABOLISM; LIVER CELL; MONOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

EID: 33644767028     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/diabetes.55.01.06.db05-0633     Document Type: Article

References (47)

1. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group: Intensive diabetes therapy and carotid intima-medial thickness in type 1 diabetes mellitus. N Engl J Med 348:2294-2303, 2003
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKSPDS 33). Lancet 352:837-853, 1998
3. Bierhaus A, Hofmann MA, Ziegler R, Nawroth PP: AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus I. The AGE concept. Cardiovasc Res 37:586-600, 1998
4. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D: Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395-1403, 1995
5. Scivittaro V, Ganz MB, Weiss MF: AGEs induce oxidative stress and activate protein kinase C-beta(II) in neonatal mesangial cells. Am J Physiol Renal Physiol 278:F676-F683, 2000
6. Lagaud GJ, Masih-Khan E, Kai S, van Breemen C, Dube GP: Influence of type II diabetes on arterial tone and endothelial function in murine mesenteric resistance arteries. J Vasc Res 38:578-589, 2001
7. Heart Outcomes Prevention Evaluation Study Investigators: Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 355:253-259, 2000
8. Lonn EM, Yusuf S, Dzavik V, Doris CI, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley WA, Teo KK, for the SECURE Investigators: Effects of Ramipril and vitamin E on atherosclerosis: the Study to Evaluate Cartotid Ultrasound Changes in Patients Treated with Ramipril and Vitamin E (SECURE). Circulation 103:919-925, 2001
9. McQuillan BM, Hung J, Beilby JP, Nidorf M, Thompson PL: Antioxidant vitamins and the risk of carotid atherosclerosis: the Perth Carotid Ultrasound Disease Assessment Study (CUDAS). J Am Coll Cardiol 38:1788-1784, 2001
10. Lonn E, Bosch J, Yusuf S, Sheridan P, Pogue J, Arnold JM, Ross C, Arnold A, Sleight P, Probstfield J, Dagenais GR, HOPE and HOPE-TOO Trial Investigators: Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293:1338-1347, 2005
11. Hawkins M, Angelov I, Liu R, Barzilai N, Rossetti L: The tissue concentration of UDP-N-acetylglucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake. J Biol Chem 272:4889-4895, 1997
12. Marshall S, Bacote V, Traxinger RR: Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-4712, 1991
13. Lui K, Paterson AJ, Chin E, Kudlow JE: Glucose stimulates protein modification by O-linked GlcNAc in pancreatic beta cells: linkage of O-linked GlcNAc to beta cell death. Proc Natl Acad Sci U S A 14:2820-2825, 2000
14. Stender S, Astrup P: Glucosamine and experimental atherosclerosis: increased wet weight and changed composition of cholesterol fatty acids in aorta of rabbits fed a cholesterol-enriched diet with added glucosamine. Atherosclerosis 26:205-213, 1977
15. Lin H, Masso-Welsh P, Di Y, Cai J, Shen J, Subjeck JR: The 170-kDa glucose-regulated stress protein is an endoplasmic reticulum protein that binds immunoglobulin. Mol Biol Cell 4:1109-1119, 1993
16. Miskovic D, Salter-Cid L, Ohan N, Flajnik M, Heikkila JJ: Isolation and characterization of a cDNA encoding a Xenopus immunoglobulin binding protein, BiP (GRP78). Comp Biochem Physiol 116:227-234, 1997
17. Morin MJ, Porter CW, McKernan P, Bernacki RJ: The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells. J Cell Physiol 114:162-172, 1993
18. Zhou J, Werstuck GH, Lhotak S, de Koning AB, Sood SK, Hossain GS, Moller J, Ritskes-Hoitinga M, Falk E, Dayal S, Lentz SR, Austin RC: Association of multiple cellular stress pathways with accelerated atherosclerosis in hyperhomocysteinemic apolipoprotein E-deficient mice. Circulation 110:207-213, 2004
19. Kunjathoor VV, Wilson D, LeBoeuf RC: Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97:1767-1773, 1996
20. Park L, Raman KG, Lee KJ, Lu Y, Ferran LJ Jr, Chow WS, Stern D, Schmidt AM: Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4:1025-1031, 1998
21. Rigotti A, Trigatti BL, Penman M, Rayburn H, Herz J, Krieger MA: Targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc Natl Acad Sci U S A 94:12610-12615, 1997
22. Kruth HS: Histochemical detection of esterified cholesterol within human atherosclerotic lesions using the fluorescent probe filipin. Atherosclerosis 51:281-292, 1984
23. Kim AJ, Shi YY, Austin RC, Werstuck GH: Valproate protects cells from endoplasmic reticulum stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase 3. J Cell Sci 118:89-99, 2005
24. Werstuck GH, Lentz SR, Dayal S, Shi Y, Hossain GS, Sood SK, Krisans SK, Austin RC: Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 107:1263-1273, 2001
25. Outinen PA, Sood SK, Pfeifer SI, Pamidi S, Podor TJ, Li J, Weitz JI, Austin RC: Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells. Blood 94:959-967, 1999
26. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA: Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68:231-240, 1987
27. Comer FI, Vosseller K, Wells L, Accavitti MA, Hart GW: Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal Biochem 293:169-177, 2001
28. Han I, Oh E, Kudlow JE: Responsiveness of the state of O-linked N-acetylglucosamine modification of nuclear pore protein p62 to the extracellular glucose concentration. Biochem J 350:109-114,2000
29. Haltiwanger RS, Grove K, Philipsberg GA: Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy- D-glucopyranosylidene)amino-N-phenylcarbamate. J Biol Chem 273:3611-3617, 1998
30. Lee JN, Ye J: Proteolytic activation of SREBP induced by cellular stress through the depletion of Insig-1. J Biol Chem 279:45257-45265, 2004
31. Jiang HY, Wek SA, McGrath BC, Scheuner D, Kaufman RJ, Cavener DR, Wek RC: Phosphorylation of the alpha subunit of eukaryotic initiation factor 2 is required for activation of NF-kappaB in response to diverse cellular stresses. Mol Cell Biol 23:5651-5663, 2003
32. Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, Herrath MG, Chait A, Bornfeldt KE: Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 114:659-668, 2004
33. Forbes JM, Yee LT, Thallas V, Lassila M, Candido R, Jandeleit-Dahm KA, Thomas MC, Burns WC, Deemer EK, Thorpe SM, Cooper ME, Allen TJ: Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis. Diabetes 53:1813-1823, 2004
34. Bucciarelli LG, Wendt T, Qu W, Lu Y, Lalla E, Rong LL, Goova MT, Moser B, Kislinger T, Lee DC, Kashyap Y, Stern DM, Schmidt AM: RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 106:2827-2835, 2002
35. Han I, Kudlow JE: Reduced O glycosylation of SP1 is associated with increased proteasome susceptibility. Mol Cell Biol 17:2550-2558, 1997
36. Du XL, Edelstein D, Dimmeler S, Ju Q, Sui C, Brownlee M: Hyperglycemia inhibits nitric oxide synthase activity by posttranslational modification at the Akt site. J Clin Invest 108:1341-1348, 2001
37. Kaufman RJ: Stress signalling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 13:1211-1233, 1999
38. Zinszner H, Kuroda M, Wang X-Z, Batchvarova N, Lightfoot RT, Remotti H, Stevens JL, Ron D: CHOP is implicated in programmed cell death in response to impaired function of the endoplasmic reticulum. Genes Dev 12:982-995, 1998
39. Parfett CLJ, Brudzynski K, Stiller C: Enhanced accumulation of mRNA for 78-kilodalton glucose-regulated protein (GRP78) in tissues of nonobese diabetic mice. Biochem Cell Biol 68:1428-1432, 1990
40. de Virgilio M, Kitzmuller C, Schwaiger E, Klein M, Kreibich G, Ivessa NE: Degradation of a short-lived glycoprotein from the lumen of the endoplasmic reticulum: the role of N-linked glycans and the unfolded protein response. Mol Biol Cell 10:4059-4073, 1999
41. Vosseller K, Wells L, Lane MD, Hart GW: Elevated nucleoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A 99:5313-5318, 2002
42. Parker GJ, Lund KC, Taylor RP, McClain DA: Insulin resistance of glycogen synthase mediated by O-linked N-acetylglycosamine. J Biol Chem 278:10022-10027, 2003
43. Shank KJ, Su P, Brglez I, Boss WF, Dewey RE, Boston RS: Induction of lipid metabolic enzymes during the endoplasmic reticulum stress response in plants. Plant Physiol 126:267-277, 2001
44. Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL: Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a. J Clin Invest 98:1575-1584, 1996
45. Li Y, Schwabe RF, Devries-Seimon T, Yao PM, Gerbod-Giannone MC, Tall AR, Davis RJ, Flavell R, Brenner DA, Tabas I: Free cholesterol-loaded macrophages are an abundant source of TNF-alpha and IL-6: model of NF-kappa B- and MAP kinase-dependent inflammation in advanced atherosclerosis. J Biol Chem 280:21763-21772, 2005
46. Hossain GS, van Thienen JV, Werstuck GH, Zhou J, Sood SK, Dickhout JG, de Koning AB, Tang D, Wu D, Falk E, Poddar R, Jacobsen DW, Zhang K, Kaufman RJ, Austin RC: TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death and contributes to the development of atherosclerosis in hyperhomocysteinemia. J Biol Chem 278:30317-30327, 2003
47. Özcan U, Cao Q, Yilmaz E, Lee A-H, Iwakoshi NN, Özdelen E, Tuncman G, Görgun C, Glimcher LH, Hotamisligil GS: Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306:457-461, 2004